Summary of population and results
| Summary | |
|---|---|
| Age (median) (IQR) (yr) | 64 (57–76) |
| Male (No.) (%) | 38 (68%) |
| Hypertension (No.) (%) | 41 (71%) |
| Diabetes (No.) (%) | 17 (29%) |
| Dyslipidemia (No.) (%) | 41 (71%) |
| Current aspirin use (No.) (%) | 22 (38%) |
| Current clopidogrel use (No.) (%) | 6 (10%) |
| Current/former smoker (No.) (%) | 22 (38%)/14 (24%) |
| Baseline NIHSS (median) (IQR) | 15 (11–20) |
| Baseline ASPECTS 8–10/5–7 (No.) (%) | 47 (81%)/11 (19%) |
| Carotid Terminus occlusion (No.) (%) | 25 (43%) |
| M1 occlusion (No.) (%) | 22 (38%) |
| M2 occlusion, (No.) (%) | 11 (19%) |
| tPA administration (No.) (%) | 25 (43%) |
| Acute angioplasty alone (No.) (%) | 20 (34%) |
| Acute angioplasty and stent placement (No.) (%) | 38 (66%) |
| Delayed stent or endarterectomy within a week (No.) (%) | 6 (10%) |
| mTICI score > 2a (No.) (%) | 56 (96%) |
| Acute carotid artery re-occlusion (No.) (%) | 4 (7%) |
| Any ICH (No.) (%) | 18 (31%) |
| Symptomatic ICH (No.) (%) | 1 (2%) |
| 30- to 60-Day carotid patency (No.) (%) | 42/49 (86%) |
| 90-Day mRS 0–2 (No.) (%) | 42 (72%) |
Note:—IQR indicates interquartile range; ICH, intracranial hemorrhage.